A former Stiefel Labs employee won a $1.5 million verdict from a Miami jury on Wednesday, vindicating claims that he was duped into selling his stock at a discount before a $2.8 billion buyout by GlaxoSmithKline. The Glaxo unit is also battling SEC claims over the buyout and could face more exposure from at least three other individuals who have brought related cases.
Greenberg Strikes Out in First Trial over Stiefel Buyout
The Litigation Daily
May 17, 2012
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.